Plain-English translation of NCT04025944 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study that gathers medical information from patients living with chronic hepatitis B or C. Researchers will look at your treatment details, lab results, and imaging scans over time to better understand how these infections progress and which treatments work best for different patients.
Although chronic viral hepatitis is a serious global health problem that can lead to liver damage and cancer, doctors don't have enough real-world information about how patients actually fare with different treatment approaches. This study aims to fill that gap by learning from patients' actual experiences in everyday medical care.
You likely qualify if…
You likely don't qualify if…
You would not receive any new medication or treatment as part of this study. Instead, researchers would collect information from your medical records, including details about any antiviral therapy you're already taking, your lab test results, and imaging scans. Your data would be analyzed alongside information from thousands of other hepatitis patients to help doctors understand long-term outcomes and improve treatment strategies.
AI-generated summary from trial data · Aug 28, 2026 · Not medical advice
China
Enrollment target
~10,000 participants
Started
July 2019
Primary completion
August 2024
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 75 Years
Last updated on clinicaltrials.gov in July 2019.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yiqi Yu, Doctor
Huashan Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.